CCL5 and hepatocellular carcinoma: Low RANTES expression levels were linked to an advanced tumor stage and to a worse prognosis.43 A decrease in circulating RANTES compared to healthy controls was also found in a study on patients with liver cirrhosis, with or without HCC.